- Home
- ZYXI vs DYAI Comparison
ZYXI vs DYAI Comparison
Compare ZYXI & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZYXI | DYAI |
|---|---|---|
| Founded | 1996 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.8M | 30.2M |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | ZYXI | DYAI |
|---|---|---|
| Price | $0.74 | $0.91 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $3.00 | $3.00 |
| AVG Volume (30 Days) | ★ 14.6M | 527.8K |
| Earning Date | 11-17-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $108,202,000.00 | $3,342,195.00 |
| Revenue This Year | N/A | $12.52 |
| Revenue Next Year | $9.30 | $92.04 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.38 | $0.71 |
| 52 Week High | $8.72 | $2.20 |
Technical Indicators
Market Signals| Indicator | ZYXI | DYAI |
|---|---|---|
| Relative Strength Index (RSI) | 42.36 | 43.36 |
| Support Level | $0.75 | $0.89 |
| Resistance Level | $0.95 | $1.04 |
| Average True Range (ATR) | 0.29 | 0.10 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 7.48 | 21.01 |
Price Performance
Historical ComparisonAbout ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.